share_log

Oklo, CleanSpark And Wolfspeed Are Among Top 7 Mid Cap Gainers Last Week (Oct 14-18): Are The Others In Your Portfolio?

Benzinga ·  05:22

These seven mid-cap stocks were the best performers in the last week. Are they in your portfolio?

  1. Oklo Inc.'s (NYSE:OKLO) stock gained 99.23% last week. Nuclear-linked stocks gained after Amazon Inc.'s (NASDAQ:AMZN) AWS announced plans to invest over $500 million in nuclear power.
  2. Wave Life Sciences Ltd. (NASDAQ:WVE) shares jumped 67.35% after the company achieved its first-ever therapeutic RNA editing in humans from its RestorAATion-2 trial of WVE-006 for Alpha-1 antitrypsin deficiency. Several analysts raised the price target on the stock.
  3. Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) gained 52.21% after the company announced it would be acquired by Lundbeck for $60 per share in cash.
  4. Wolfspeed, Inc. (NYSE:WOLF) shares rocketed 42.44% after signing a non-binding preliminary memorandum of terms for up to $750 million in proposed direct funding under the CHIPS and Science Act.
  5. CleanSpark, Inc. (NASDAQ:CLSK) stock upped 34.10% last week after Bitcoin (CRYPTO: BTC) rose above $67,000.
  6. Telephone and Data Systems, Inc. (NYS: TDS) soared 26.03% after the company announced its subsidiary, United State Cellular Corp (NYSE:USM), selling select spectrum licenses in the AWS and PCS bands.
  7. IonQ, Inc. (NYSE:IONQ) shares increased 15.31%. The company will report third-quarter financial results on November 6.

Also Read:

  • NIO, ASML, And CVS Health Are Among Top 10 Large Cap Losers Last Week (Oct 14-18): Are The Others In Your Portfolio?
  • Coinbase, United Airlines And Sofi Tech Are Among Top 11 Large Cap Gainers Last Week (Oct 14-18): Are The Others In Your Portfolio?

Photo Courtesy of Oklo

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment